Heart Valve Disease: Recent Advances in Therapeutic Approaches

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: 14 June 2024 | Viewed by 737

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cardiothoracic Surgery, Augsburg University Hospital, Augsburg, Germany
Interests: heart valve disease; stenosis; regurgitation; prolapse; transcatheteraortic valve implantation; balloon valvuloplasty

Special Issue Information

Dear Colleagues,

As the population ages, heart valve disease becomes a growing health problem worldwide. Heart valves, including the aortic valve, mitral valve, pulmonary valve and tricuspid valve, control the direction of your blood flow. Heart valve disease is a common condition that one or more of the valves do not open or close properly. The causes are often linked to birth defects, age or other conditions. In the past, medication and open-heart surgery are the common treatments for heart valve diseases. However, with the advances in medical technology, a range of innovative, minimally invasive procedures are developed, such as transcatheter aortic valve replacement (TAVR), percutaneous mitral valve repair (MitraClip) and robotic mitral valve repair.

This Special Issue aims to collate state-of-the-art research on heart valve disease. Original articles, reviews, and communications are welcome. We look forward to receiving your contributions.

Prof. Dr. Evaldas Girdauskas
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart valve disease
  • stenosis
  • regurgitation
  • prolapse
  • transcatheter
  • aortic valve implantation
  • balloon valvuloplasty

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 1727 KiB  
Article
Bicuspid Morphology and Rapid Deployment Valve Replacement: Is This Still a Contraindication?
by Julia von der Linden, Florian Herrmann, Sergey Belyaev, Gerd Juchem, Sven Peterss, Christian Hagl and Alexey Dashkevich
J. Clin. Med. 2023, 12(23), 7390; https://doi.org/10.3390/jcm12237390 - 29 Nov 2023
Viewed by 563
Abstract
When using rapid deployment surgical aortic valve replacement (RD SAVR) in treating bicuspid aortic valve morphology (BAV), several challenges are faced due to annular asymmetry. The Sievers classification has been traditionally used for the description of BAV morphology. In this study, we aimed [...] Read more.
When using rapid deployment surgical aortic valve replacement (RD SAVR) in treating bicuspid aortic valve morphology (BAV), several challenges are faced due to annular asymmetry. The Sievers classification has been traditionally used for the description of BAV morphology. In this study, we aimed to conduct a retrospective feasibility analysis of RD SAVR in relation to the Sievers classification. From January 2014 to March 2022, 31 patients with BAV morphology (15 patients with Sievers type 0 BAV and 16 with Sievers type 1 BAV) underwent RD SAVR. Specific surgical techniques were applied depending on the BAV morphology. Comparable clinical outcomes were observed. No paravalvular leaks and no valvular re-interventions occurred in either group. CPB and cross-clamping times, as well as the prosthesis sizes used, were also not significantly different. Postoperative mean gradients were comparable in both groups. No significant distinction was found between the groups in terms of postoperative pacemaker indication, postoperative stroke, or death. Annular symmetry can be adequately restored through precise prosthesis sizing and placement according to an individual’s valve morphology regardless of the Sievers classification of BAV by choosing a different landmark for the initial suture. RD SAVR seems to be a safe approach for any bicuspid morphology, with good hemodynamic results and time-saving potential in experienced hands. Full article
(This article belongs to the Special Issue Heart Valve Disease: Recent Advances in Therapeutic Approaches)
Show Figures

Graphical abstract

Back to TopTop